The present paper discusses the consequences of nocturia in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) and summarises the available data on the impact of tamsulosin oral controlled absorption system (OCAS) on nocturia. The opinions of urologists on these data were assessed during a closed meeting in Marbella, Spain.
Nocturia is the most bothersome symptom of LUTS/BPH. Especially waking up during the first 3–4
Interactive voting showed that the majority of urologists attending the closed meeting in Marbella agreed with the statements that “sleep disturbance is the major reason why nocturia is so bothersome,” that “nocturia is the most bothersome urinary symptom because it affects QoS,” that “HUS should be a key parameter for evaluating the effects of LUTS/BPH treatment on sleep,” and that “LUTS/BPH treatments should be evaluated for their effects on QoS and QoL.”
Keywords: Benign prostatic hyperplasia, Lower urinary tract symptoms, Nocturia, Oral controlled absorption system, Sleep, Tamsulosin, Quality of life.
© 2007 European Association of Urology, Published by Elsevier B.V.